Opportunities for the development of novel therapies based on host-microbial interactions
Display Omitted
Gespeichert in:
| Autor*in: |
Santos, Patrícia Campi [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
16 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China - Deng, Lixing ELSEVIER, 2022, the official journal of the Italian Pharmacological Society, London |
|---|---|
| Übergeordnetes Werk: |
volume:112 ; year:2016 ; pages:68-83 ; extent:16 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.phrs.2016.04.005 |
|---|
| Katalog-ID: |
ELV024732966 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV024732966 | ||
| 003 | DE-627 | ||
| 005 | 20230623174713.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.phrs.2016.04.005 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016018000017.pica |
| 035 | |a (DE-627)ELV024732966 | ||
| 035 | |a (ELSEVIER)S1043-6618(16)30290-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 330 |q VZ |
| 100 | 1 | |a Santos, Patrícia Campi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Opportunities for the development of novel therapies based on host-microbial interactions |
| 264 | 1 | |c 2016 | |
| 300 | |a 16 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Display Omitted | ||
| 650 | 7 | |a Therapeutic potential targets |2 Elsevier | |
| 650 | 7 | |a Platelet-activating factor (PAF) |2 Elsevier | |
| 650 | 7 | |a Infection disease |2 Elsevier | |
| 650 | 7 | |a Inflammatory response |2 Elsevier | |
| 650 | 7 | |a Host microbial interaction |2 Elsevier | |
| 700 | 1 | |a Teixeira, Mauro Martins |4 oth | |
| 700 | 1 | |a Souza, Danielle G. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Academic Press |a Deng, Lixing ELSEVIER |t Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |d 2022 |d the official journal of the Italian Pharmacological Society |g London |w (DE-627)ELV008224951 |
| 773 | 1 | 8 | |g volume:112 |g year:2016 |g pages:68-83 |g extent:16 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.phrs.2016.04.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 951 | |a AR | ||
| 952 | |d 112 |j 2016 |h 68-83 |g 16 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
p c s pc pcs |
|---|---|
| matchkey_str |
santospatrciacampiteixeiramauromartinsso:2016----:potntefrhdvlpetfoeteaisaeohs |
| hierarchy_sort_str |
2016 |
| publishDate |
2016 |
| allfields |
10.1016/j.phrs.2016.04.005 doi GBVA2016018000017.pica (DE-627)ELV024732966 (ELSEVIER)S1043-6618(16)30290-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Santos, Patrícia Campi verfasserin aut Opportunities for the development of novel therapies based on host-microbial interactions 2016 16 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Therapeutic potential targets Elsevier Platelet-activating factor (PAF) Elsevier Infection disease Elsevier Inflammatory response Elsevier Host microbial interaction Elsevier Teixeira, Mauro Martins oth Souza, Danielle G. oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:112 year:2016 pages:68-83 extent:16 https://doi.org/10.1016/j.phrs.2016.04.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 112 2016 68-83 16 045F 610 |
| spelling |
10.1016/j.phrs.2016.04.005 doi GBVA2016018000017.pica (DE-627)ELV024732966 (ELSEVIER)S1043-6618(16)30290-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Santos, Patrícia Campi verfasserin aut Opportunities for the development of novel therapies based on host-microbial interactions 2016 16 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Therapeutic potential targets Elsevier Platelet-activating factor (PAF) Elsevier Infection disease Elsevier Inflammatory response Elsevier Host microbial interaction Elsevier Teixeira, Mauro Martins oth Souza, Danielle G. oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:112 year:2016 pages:68-83 extent:16 https://doi.org/10.1016/j.phrs.2016.04.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 112 2016 68-83 16 045F 610 |
| allfields_unstemmed |
10.1016/j.phrs.2016.04.005 doi GBVA2016018000017.pica (DE-627)ELV024732966 (ELSEVIER)S1043-6618(16)30290-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Santos, Patrícia Campi verfasserin aut Opportunities for the development of novel therapies based on host-microbial interactions 2016 16 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Therapeutic potential targets Elsevier Platelet-activating factor (PAF) Elsevier Infection disease Elsevier Inflammatory response Elsevier Host microbial interaction Elsevier Teixeira, Mauro Martins oth Souza, Danielle G. oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:112 year:2016 pages:68-83 extent:16 https://doi.org/10.1016/j.phrs.2016.04.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 112 2016 68-83 16 045F 610 |
| allfieldsGer |
10.1016/j.phrs.2016.04.005 doi GBVA2016018000017.pica (DE-627)ELV024732966 (ELSEVIER)S1043-6618(16)30290-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Santos, Patrícia Campi verfasserin aut Opportunities for the development of novel therapies based on host-microbial interactions 2016 16 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Therapeutic potential targets Elsevier Platelet-activating factor (PAF) Elsevier Infection disease Elsevier Inflammatory response Elsevier Host microbial interaction Elsevier Teixeira, Mauro Martins oth Souza, Danielle G. oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:112 year:2016 pages:68-83 extent:16 https://doi.org/10.1016/j.phrs.2016.04.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 112 2016 68-83 16 045F 610 |
| allfieldsSound |
10.1016/j.phrs.2016.04.005 doi GBVA2016018000017.pica (DE-627)ELV024732966 (ELSEVIER)S1043-6618(16)30290-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 330 VZ Santos, Patrícia Campi verfasserin aut Opportunities for the development of novel therapies based on host-microbial interactions 2016 16 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Therapeutic potential targets Elsevier Platelet-activating factor (PAF) Elsevier Infection disease Elsevier Inflammatory response Elsevier Host microbial interaction Elsevier Teixeira, Mauro Martins oth Souza, Danielle G. oth Enthalten in Academic Press Deng, Lixing ELSEVIER Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China 2022 the official journal of the Italian Pharmacological Society London (DE-627)ELV008224951 volume:112 year:2016 pages:68-83 extent:16 https://doi.org/10.1016/j.phrs.2016.04.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U AR 112 2016 68-83 16 045F 610 |
| language |
English |
| source |
Enthalten in Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China London volume:112 year:2016 pages:68-83 extent:16 |
| sourceStr |
Enthalten in Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China London volume:112 year:2016 pages:68-83 extent:16 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Therapeutic potential targets Platelet-activating factor (PAF) Infection disease Inflammatory response Host microbial interaction |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| authorswithroles_txt_mv |
Santos, Patrícia Campi @@aut@@ Teixeira, Mauro Martins @@oth@@ Souza, Danielle G. @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV008224951 |
| dewey-sort |
3610 |
| id |
ELV024732966 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV024732966</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623174713.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.phrs.2016.04.005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016018000017.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV024732966</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1043-6618(16)30290-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">330</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Santos, Patrícia Campi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Opportunities for the development of novel therapies based on host-microbial interactions</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">16</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Therapeutic potential targets</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Platelet-activating factor (PAF)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Infection disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inflammatory response</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Host microbial interaction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Teixeira, Mauro Martins</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Souza, Danielle G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Deng, Lixing ELSEVIER</subfield><subfield code="t">Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China</subfield><subfield code="d">2022</subfield><subfield code="d">the official journal of the Italian Pharmacological Society</subfield><subfield code="g">London</subfield><subfield code="w">(DE-627)ELV008224951</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:112</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:68-83</subfield><subfield code="g">extent:16</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.phrs.2016.04.005</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">112</subfield><subfield code="j">2016</subfield><subfield code="h">68-83</subfield><subfield code="g">16</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Santos, Patrícia Campi |
| spellingShingle |
Santos, Patrícia Campi ddc 610 ddc 330 Elsevier Therapeutic potential targets Elsevier Platelet-activating factor (PAF) Elsevier Infection disease Elsevier Inflammatory response Elsevier Host microbial interaction Opportunities for the development of novel therapies based on host-microbial interactions |
| authorStr |
Santos, Patrícia Campi |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008224951 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 330 - Economics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 330 VZ Opportunities for the development of novel therapies based on host-microbial interactions Therapeutic potential targets Elsevier Platelet-activating factor (PAF) Elsevier Infection disease Elsevier Inflammatory response Elsevier Host microbial interaction Elsevier |
| topic |
ddc 610 ddc 330 Elsevier Therapeutic potential targets Elsevier Platelet-activating factor (PAF) Elsevier Infection disease Elsevier Inflammatory response Elsevier Host microbial interaction |
| topic_unstemmed |
ddc 610 ddc 330 Elsevier Therapeutic potential targets Elsevier Platelet-activating factor (PAF) Elsevier Infection disease Elsevier Inflammatory response Elsevier Host microbial interaction |
| topic_browse |
ddc 610 ddc 330 Elsevier Therapeutic potential targets Elsevier Platelet-activating factor (PAF) Elsevier Infection disease Elsevier Inflammatory response Elsevier Host microbial interaction |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
m m t mm mmt d g s dg dgs |
| hierarchy_parent_title |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| hierarchy_parent_id |
ELV008224951 |
| dewey-tens |
610 - Medicine & health 330 - Economics |
| hierarchy_top_title |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008224951 |
| title |
Opportunities for the development of novel therapies based on host-microbial interactions |
| ctrlnum |
(DE-627)ELV024732966 (ELSEVIER)S1043-6618(16)30290-0 |
| title_full |
Opportunities for the development of novel therapies based on host-microbial interactions |
| author_sort |
Santos, Patrícia Campi |
| journal |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| journalStr |
Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
68 |
| author_browse |
Santos, Patrícia Campi |
| container_volume |
112 |
| physical |
16 |
| class |
610 610 DE-600 330 VZ |
| format_se |
Elektronische Aufsätze |
| author-letter |
Santos, Patrícia Campi |
| doi_str_mv |
10.1016/j.phrs.2016.04.005 |
| dewey-full |
610 330 |
| title_sort |
opportunities for the development of novel therapies based on host-microbial interactions |
| title_auth |
Opportunities for the development of novel therapies based on host-microbial interactions |
| abstract |
Display Omitted |
| abstractGer |
Display Omitted |
| abstract_unstemmed |
Display Omitted |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Opportunities for the development of novel therapies based on host-microbial interactions |
| url |
https://doi.org/10.1016/j.phrs.2016.04.005 |
| remote_bool |
true |
| author2 |
Teixeira, Mauro Martins Souza, Danielle G. |
| author2Str |
Teixeira, Mauro Martins Souza, Danielle G. |
| ppnlink |
ELV008224951 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth |
| doi_str |
10.1016/j.phrs.2016.04.005 |
| up_date |
2024-07-06T22:11:56.917Z |
| _version_ |
1803869399986208768 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV024732966</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623174713.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.phrs.2016.04.005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016018000017.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV024732966</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1043-6618(16)30290-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">330</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Santos, Patrícia Campi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Opportunities for the development of novel therapies based on host-microbial interactions</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">16</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Therapeutic potential targets</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Platelet-activating factor (PAF)</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Infection disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Inflammatory response</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Host microbial interaction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Teixeira, Mauro Martins</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Souza, Danielle G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Academic Press</subfield><subfield code="a">Deng, Lixing ELSEVIER</subfield><subfield code="t">Social insurance premiums and corporate cash holdings: Evidence from social insurance law in China</subfield><subfield code="d">2022</subfield><subfield code="d">the official journal of the Italian Pharmacological Society</subfield><subfield code="g">London</subfield><subfield code="w">(DE-627)ELV008224951</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:112</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:68-83</subfield><subfield code="g">extent:16</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.phrs.2016.04.005</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">112</subfield><subfield code="j">2016</subfield><subfield code="h">68-83</subfield><subfield code="g">16</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3974257 |